Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
-386K
-
Total reported value, excl. options
-
$128M
-
Value change
-
-$2.32M
-
Number of buys
-
13
-
Number of sells
-
-16
-
Price
-
$5.90
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2016
41 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q4 2016.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
of 71.9M outstanding shares and own 30.21% of the company stock.
Largest 10 shareholders include SAIF Advisors Ltd (10.8M shares), WELLINGTON MANAGEMENT GROUP LLP (5.52M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.52M shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (346K shares), Eqis Capital Management, Inc. (175K shares), TWO SIGMA INVESTMENTS, LP (116K shares), Invesco Ltd. (99.5K shares), DEUTSCHE BANK AG\ (84.4K shares), and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (64.7K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.